Clinical Trial Update: Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on adjuvant HIPEC to prevent colorectal peritoneal metastases in high-risk patients; Phase 1 and Phase 2 studies are completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Colorectal Neoplasm, Metastasis | Phase 1, Phase 2 | Status: COMPLETED